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INTRODUCTION
Accumulating evidence demonstrates that a series
of genetic alterations are involved inmulti-stage colon
carcinogenesis (1). In addition, it has been recog-
nized that various dietary carcinogens play an impor-
tant role in the development of colon cancers (2-4).
Our previous study showed that unknownDNAadducts
were formed in the human colonic mucosa (5) at a
level apparently higher than that of the small intes-
tinal mucosa which shows a much lower incidence
of cancer (6). Such DNA adducts may be the cause of
critical mutations in cancer-related genes. A heterocyclic
amine 2-amino-3-methylimidazo [4,5 - f] quinoline (IQ)
(Fig. 1) is shown to develop a high incidence of tumors
in the small and large intestine, liver, Zymbal gland,
clitoral gland and skin in F344 rats (7). IQ is sug-
gested to be generated from creatine, free amino acids
and hexoses, present in raw meat, via the Maillard
reaction during the cooking process (8), and so is re-
cognized as an unavoidable dietary component for
humans. IQ forms N-(deoxyguanosin-8-yl)-2-amino-3-
methylimidazo-[4,5-f ]quinoline (dG-C8-IQ) and 5-
(deoxyguanosin-N 2-yl)-2-amino-3-methylimidazo[4,5-f]
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1.51 and 1.37 when IQ was administered into the stomach (n=6) and the vein (n=5), respec-
tively. This suggested that luminal exposure of IQ induced DNA adduct formation. Since
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Fig. 1. Structures of 2-amino-3-methylimidazo[4,5-f ]quinoline
(IQ), dG-C 8-IQ and dG-N 2-IQ.
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quinoline (dG-N 2-IQ) in vitro and in vivo (9-11) (Fig. 1).
Although IQ-DNA adduct levels in F 344 rats were
highest in the liver, followed, in order, by the lungs,
kidneys, stomach, colon, white blood cells and small
intestine (12), the carcinogenic targets were only the
liver, small intestine and colon. The threshold for the
initiation of carcinogenesis by the adducts, repair
of the adducts and cell turnover rate in each tissue
may be responsible for this discrepancy. Thus, the
relationship between the DNA adduct level and
tumorigenesis is not a simple matter of cause and
effect. However, it has been demonstrated that IQ
induced point mutations inH-ras and K-ras genes in
Zymbal gland tumors (13) and in Apc and β-catenin
genes in colon tumors (14, 15). Thus, the DNA ad-
duct formation and subsequent gene mutations are
presumably the major mechanism for the rat colon
carcinogenesis by IQ.
There are three theoretical routes by which IQ,
administered by gavage, can come into contact with
colonic mucosal DNA (16) : (i) Luminal exposure :
IQ in the stomach travels through the intestinal lu-
men and reaches the colonic mucosal cells from the
luminal direction, (ii) Circulatory exposure : IQ is ab-
sorbed from the gastrointestinal tract, metabolized
in the liver, and transferred to the colonic cells through
systemic blood circulation, (iii) Biliary exposure : after
absorption from the GI-tract, IQ is metabolized in the
liver, and excreted into bile, reaching the luminal
surface of the colonic mucosa. However, it is not yet
thoroughly clarified how these routes work for DNA
adduct formation in the colon. In the present study,
the colostomized rats having normal proximal colon
and fecal stream-excluded distal colon were used to
clarify the role of each route.
MATERIALS AND METHODS
Chemicals
IQ-HCl was from Dr. Keiji Wakabayashi, National
Cancer Center Research Institute, Japan. RNase A,
RNase T1,micrococcal nuclease, spleenphosphodiesterase
and phosphodiesterase I were purchased fromWorthington
Biochemical Co. Ltd. (Freehold, NJ). T4 polynucleotide
kinase was obtained from Pharmacia Fine Chemicals
(Uppsala, Sweden). Nuclease P1 was purchased from
Yamasa Shoyu Co., Ltd. (Choshi, Japan). Proteinase
K and apyrase were purchased from Sigma (St. Louis,
MO). [α-32P]adenosine-5’-triphosphate (>7,000 Ci/
mmol) was obtained from ICN Radiochemical (Irvine,
CA). Polyethyleneimine-cellulose sheets (POLYGRAM
CELL 300 PEI) were purchased fromMachery-Nagel
(Duren, Germany).
Animals
Male Fischer 344 rats (4-6 weeks old) were pur-
chased from Nippon SLC Co. (Hamamatsu, Japan)
and housed in polycarbonate cages, two to three
animals per cage, for one week prior to use in the
pathogen-free room of our animal facilities. They were
kept under constant conditions of temperature (22
±2℃) and humidity (55±5%) with a 13 hr light/11
hr dark cycle. They were fed a commercial diet MF
(Oriental Yeast, Co., Ltd., Tokyo, Japan) and provided
tap water ad libitum.
Study design and surgery
Male F344 rats underwent surgery to differentiate
the transportation routes in rat body for IQ (Fig. 2).
In all the experimental studies, laparotomy was per-
formed under general anesthesia with intraperitoneal
administration of pentobarbital sodium (50 mg/kg
b.w.). In Study 1, rats (6 weeks old) were colostomized
at the middle of the transverse colon, and the divided
colonic stumps were separately anchored through
the abdominal wall to the exterior (Fig. 3A-C). Using
this procedure, the distal side of the colon was com-
pletely separated from the fecal stream and natur-
ally became empty within a few days. The distal colon
was further cleaned up by enema with 0.9% NaCl so-
lution from the stoma for three days before dosing.
A single dose of IQ-HCl (50 mg/kg, 20 mg/ml of water
solution) was administered into the stomach (n=6)
in Study 1A, into the excluded distal colon (n=5) in
Study 1B and intravenously (n=5) in Study 1C two
weeks after colostomy. In Study 1B, immediately after
administration of IQ into the distal colon via the stoma,
the stoma and the anus of the distal colonwere stitched
to avoid leakage. In Study 2, the bile duct of the rats
(8 weeks old) was catheterized under laparotomy
(n=5) and bile was drained for 24 hr after intravenous
administration of IQ-HCl (50 mg/kg) (Fig. 3D). In
all experiments, the rats were sacrificed 24 hr after
administration of IQ by carbon dioxide asphyxiation,
and the large intestines were collected. The intestines
were incised in a longitudinal direction and immedi-
ately rinsed free of their contents with 0.9% NaCl
solution. The mucosal layer was scraped off, and the
separated mucosal layers and muscle layers were
stored at -80℃ until use.
32P-postlabeling of IQ-DNA adducts
DNA was isolated by the method reported previ-
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ously (5, 17). The concentration ofDNAwas determined
by measuring the absorbance at 260 nm (using a value
of 20 absorbance units/mg DNA) and adjusted to a
final concentration of 2 mg/ml. IQ-DNA adducts were
detected by 32P-postlabeling analysis with the inten-
sification method (18). Briefly, 10 µg of DNA was di-
gested to deoxynucleoside 3’-monophosphates with
micrococcal nuclease (3units) andspleenphosphodiesterase
(0.03 units) in a total volume of 10 µl of 20 mM so-
dium succinate, 10 mMCaCl2, pH 6.0 at 37℃ for 3.5
hr (19). The DNA digest was diluted 2-fold with water.
Then, 10 µl of the digest was taken and incubated
Fig. 2. Study protocols. (A) Study 1A ;
(B) Study 1B ; (C) Study 1C ; (D)
Study 2.
Fig. 3. Rat surgeries and administration of IQ. (A) Study 1A : rats were colostomized, and IQ (50 mg/kg bw) was administered
into the stomach. (B) Study 1B : IQ was administered into the excluded distal colon of the colostomized rats. (C) Study 1C : IQ was
administered intravenously to the colostomized rats. (D) Study 2 : IQ was administered intravenously to the bile-drained rats.
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with 5 µl of labeling cocktail containing 1.5 µl of
kination buffer (300 mM Tris-HCl, pH 9.5, 100 mM
MgCl2, 100mMdithiothreitol and 10mMspermidine),
1.0 µl of [α-32P]ATP (150 mCi/ml), 0.5 µl (5 units)
of T4 polynucleotide kinase and 2.0 µl of water at
37℃ for 1 hr. The labeled digest was further treated
with 2 µl potato apyrase (5 units/ml) and 1 µl water
for 45 min at 37℃. To purify the IQ-bound nucleotides
from normal nucleotides, the 32P-labeled nucleoside
bisphosphates were spotted onto PEI-cellulose sheets
and developed with 1.7 M sodium phosphate (pH 6.0)
at 22℃ for 16 hr. The origin was cut out and attached
to a new PEI-cellulose sheet using a magnet, and
developed with 2.7 M lithium formate/5.1 M urea
(pH 3.5) from bottom to top. This was further de-
veloped in 0.96 M LiCl/6.4 M urea/0.4 M Tris-HCl
(pH 8.0), followed by 1.0 M sodium phosphate (pH 6.0)
from left to right, with a 3.5 cm paper wick (Whatman
3MM chromatography paper). The radioactive spots
on a thin-layer chromatography (TLC) sheet were
visualized and their radioactivity was quantified by
BAS-1500 Bio Imaging Analyzer and BAS-IIIs Imaging
Plate (Fuji Photo Film Co., Ltd, Tokyo, Japan). For
the total nucleotide count, an aliquot of the above
DNA digest was labeled, treated with apyrase, spotted
on the PEI-cellulose sheet and developed with 0.5
M lithium chloride (17). The relative adduct labeling
(RAL) values were calculated according to the for-
mula : RAL = adducts level / (total nucleotides level×
dilution factor). All experiments for quantification of
the IQ-DNA adduct level by 32P-postlabeling were per-
formed in triplicate. To estimate DNA adduct levels
as accurately as possible, all samples in a study group
were analyzed at once, and the analysis of samples
was performed in a random order. Statistical analy-
sis was performed by ANOVA.
RESULTS
In study-1, the preoperative body weight of the
rats (140±2 g) at 6 weeks old slightly decreased to
137±9 g one week after colostomy, but increased
again to 162±6 g when IQ was administered at 8
weeks of age. When IQ was administered into the
stomach (Study 1A), the IQ-DNA adduct level of the
proximal mucosa was significantly higher than that
of the distal mucosa (p<0.05), and that of the proxi-
mal muscular layer was significantly higher than that
of the distal muscular layer (p<0.05) (Table 1). In the
same study, the IQ-DNA adduct level of the proximal
mucosa was significantly higher that of the proximal
muscular layer (p<0.05), and that of the distal mucosa
was significantly higher than that of the distal mus-
cular layer (p<0.05).
When IQ was administered into the distal colon
(Study 1B), the IQ-DNA adduct level of the proximal
mucosa was similar to that of the distal mucosa, but
that of the proximal muscular layer was significantly
higher than that of the distal muscular layer (p<0.05)
(Table 1). In the same study, the IQ-DNA adduct
levels of the proximal and distal mucosa were signifi-
cantly higher than those of the proximal and distal
muscular layer, respectively (p<0.05). As a whole, the
DNA adduct level of Study 1B dosed in the distal colon
was similar to that of Study 1A dosed in the stomach.
In contrast, DNA adduct level of Study 1C dosed intra-
venously was about three-fold higher than that of
Study 1A and B.
When IQ was administered intravenously (Study
1C), the IQ-DNA adduct level of the proximal mucosa
was significantly higher than that of the distal mucosa
(p<0.05), but that of the proximal muscular layer was
no difference compared with that of the distal mus-
cular layer (Table 1). In the same study, the IQ-DNA
adduct level of the proximal mucosa was significantly
higher that of the proximal muscular layer (p<0.05),
and that of the distal mucosa was not significantly
higher than that of the distal muscular layer.
In Study 2, when IQ was administered intravenously
to the bile-drained rats, the IQ-DNA adduct level of
the mucosa was about 2-fold higher that of the mus-
cular layer (p<0.05) (Table 1). In all studies, approxi-
mately 5-6 DNA adduct spots were detected on a TLC
sheet by 32P-postlabeling analysis as reported pre-
viously (16).
DISCUSSION
Among three theoretical exposure routes of IQ to
the colon (luminal, circulatory and biliary exposures),
all routes should be potentially active in the colonic
mucosa if IQ is administered into the stomach of the
non-operated rats. However, the luminal and biliary
exposures to the distal colonic mucosa were blocked
by the colostomy (Study 1A). When IQ was admin-
istered into the distal colon of the colostomized rats,
luminal exposure to the proximal mucosa alone was
blocked, in contrast, heavy luminal exposure to the
distal mucosa occurred (Study 1B). When IQ was
administered intravenously to the colostomized rats,
luminal exposure to the mucosa was blocked (Study
1C). When IQ was administered intravenously to the
bile-drained rats, only circulatory exposure was active
(Study 2). Thus, a combination of these experimental
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models provided important information to clarify the
active exposure routes to the colon. The colostomy
procedure was an acceptable stress for the rats, and
the rats were healthy when IQ was administered. Since
the absolute values of 32P-postlabeling have a wide
error range in all experiments, the samples to be com-
pared should be analyzed together. However, the
number of samples for one time analysis is limited.
In the present study, to compare the mucosal DNA
adduct levels in the different studies, the paired
mucosa-adjacent muscular layer which allows only
circulatory exposure was analyzed as a good stan-
dard.
The general patterns of the DNA adduct levels in
four types of colonic tissues (mucosa/muscular layer
of the proximal/distal colon) were similar in Studies
1A, 1B and 1C. However, one difference was that the
DNA adduct level of the distal mucosa in Study 1B
alone was higher than that in Study 1A or 1C : i.e.
the ratio of the DNA adduct level of the distal mucosa
to the paired muscular layer was 2.02 in Study 1B,
whereas it was 1.51 in Study 1A and 1.37 in Study
1C. This suggests that luminal exposure of IQ in-
duced DNA adduct formation. Since IQ (an amine
form) has no reactivity toward DNA, these findings
imply that IQ was immediately activated in the ab-
sorbed mucosal cell and reacted with DNA. This idea
is not recognized in other heterocyclic amines (20).
The principal metabolic pathways of heterocyclic
amines leading to DNA adducts involve cytochrome
P450 (CYP) mediated N-oxidation of exocyclic amine
nitrogen (phase I) and subsequent esterification by
phase II enzymes (21). In hepatic tissue, heterocyclic
amines are known to be activated to the N -hydroxy
form mainly by CYP1A2, but this enzyme activity is
absent in the colon (22). However, in the case of IQ,
we previously demonstrated, using different rat mod-
els, that IQ was partly activated to form DNA adduct
in the colonic mucosal cells (16). The present find-
ings support our previous observations. Thus, except
CYP1A2, there should be another metabolic activa-
tion mechanism such as CYP1B1 (22) and prostaglandin
H synthase (23) in the colonic mucosa. However, the
major activation was presumably catalyzed by hepatic
CYP1A2 as previously recognized, becausemost DNA
adduct was formed via circulatory exposure in the
present study.
A comparison of DNA adduct levels of the proximal
Table 1. IQ-induced DNA adducts in colostomized rat colon
Study n Sample
Exposure route DNA adduct level
(RALa×107)Luminal Circulatory Biliary
1A 6
Proximal mucosa
Proximal muscle
Distal mucosa
Distal muscle
+b
c
+
+
+
+
+ 1.92±0.26de
1.10±0.05f
1.31±0.09g
0.87±0.05
1B 5
Proximal mucosa
Proximal muscle
Distal mucosa
Distal muscle
+
+
+
+
+
+ 1.83±0.34d
1.23±0.24f
1.68±0.19g
0.83±0.05
1C 5
Proximal mucosa
Proximal muscle
Distal mucosa
Distal muscle
+
+
+
+
+ 5.50±1.7de
3.66±0.85
3.34±0.78
2.44±0.95
2 5
Mucosa
Muscle
+
+
2.44±0.56h
1.24±0.20
IQ(50 mg/kg) was administered into the stomach of the colostomized rats (Study 1 A, n=6), distal colon of the colostomized rats
(Study 1 B, n=5), vein of the colostomized rats (Study 1 C, n=5) and vein of the bile-drained rats (Study 2, n=5), respectively.
a Relative adduct labeling.
b Active.
c Inactive.
d p<0.05 versus proximal muscle of the same rats.
e p<0.05 versus distal mucosa of the same rats.
f p<0.05 versus distal muscle of the same rats.
g p<0.05 versus distal muscle of the same rats.
h p<0.05 versus muscle of the same rats.
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mucosa between Study 2 and Study 1A-C showed the
effect of biliary exposure by IQmetabolites on colonic
DNA adduct formation. Although the biliary exposure
to the proximal mucosa was excluded by bile drainage
in Study 2, the DNAadduct level of the proximal mucosa
did not decrease compared with that in Study 1.
This suggests that the contribution of biliary IQ
metabolites to the colonic adduct formation was neg-
ligible. Therefore, the finding that the IQ-DNA adduct
level of the proximal mucosa was significantly higher
than that of the distal mucosa in Study 1C was caused
mostly by circulatory exposure. The IQ-DNA adduct
level of the proximal muscular layer was also higher
than that of the distal colon in all Study 1 experiments.
In addition, a preferential DNA adduct formation was
shown in the mucosa compared with the paired mus-
cular layer in all studies. The differences in the activ-
ities of metabolic activation/inactivation enzymes, the
transport of the cell membrane and DNA repair may
be the causes of these preferences of DNA adduct
formation.
In conclusion, the findings of the present study
suggest that most of the part of IQ (an amine form)
passes through the colonic mucosal cells without being
metabolized when absorbed, is activated to anN-hydroxy
form in hepatic tissue mainly by CYP1A2, is transported
via the systemic circulation to the colon, and forms
DNA adducts (Fig. 4). Some of the IQ, however, re-
ceives another metabolic activation allowing DNA
adduct formation in colonic cells. The role of biliary
IQ metabolites in colonic DNA adduct formation is
negligible.
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